Anabolic steroid use disorder
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
elite athlete: anabolic-androgenic steroid (AAS) use
provide evidence of approved use or discontinue AAS
Elite athletes may seek a therapeutic use exemption from the relevant antidoping agency for the use of an anabolic-androgenic steroid (AAS) for medical reasons (e.g., testosterone replacement therapy for treatment of hypogonadism resulting from Klinefelter syndrome).[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500. https://www.doi.org/10.1210/jc.2018-01882 http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com World Anti-Doping Agency: therapeutic use exemptions Opens in new window
Endocrinologists may be asked to provide evidence of the medical indication for testosterone replacement therapy. Therapeutic use exemptions for the treatment of male hypogonadism are usually only granted for testosterone or gonadotropin therapy. Therapeutic use exemptions are not usually approved retrospectively or for non-testosterone AASs.
Retired elite male athletes may present with, or develop, secondary hypogonadism without an identifiable cause. They may be unwilling to divulge previous use of AASs because of concerns that information may be leaked into the public arena with associated reputational damage, loss of lucrative endorsements, and curtailed employment opportunities in their sport.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500. https://www.doi.org/10.1210/jc.2018-01882 http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
Athletes who are found guilty of the unapproved use of an AAS must discontinue the banned substance without the use of hormone therapy to mitigate against AAS withdrawal syndrome.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500. https://www.doi.org/10.1210/jc.2018-01882 http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com No tapering is required.[38]Brooks JH, Ahmad I, Easton G. Anabolic steroid use. BMJ. 2016 Oct 13;355:i5023. http://www.ncbi.nlm.nih.gov/pubmed/27737851?tool=bestpractice.com
management of harms associated with chronic use
Treatment recommended for SOME patients in selected patient group
Warrants an interdisciplinary approach as chronic effects of AAS use, or discontinuation, may require review by a cardiologist (atherosclerosis, cardiomyopathy), endocrinologist (sexual dysfunction, infertility, other effects of hypogonadism), psychiatrist (mood disorders, body dysmorphia, depression), or addiction specialist (substance abuse).
Retired elite male athletes may present with, or develop, secondary hypogonadism without an identifiable cause. They may be unwilling to divulge previous use of AASs because of concerns that information may be leaked into the public arena with associated reputational damage, loss of lucrative endorsements, and curtailed employment opportunities in their sport.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500. https://www.doi.org/10.1210/jc.2018-01882 http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com Endocrinologic input is important.
general population: anabolic-androgenic steroid (AAS) use
support AAS discontinuation
In general, a supportive and educational approach is advised.[19]Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021 Jul 16;42(4):457-501. https://www.doi.org/10.1210/endrev/bnab001 http://www.ncbi.nlm.nih.gov/pubmed/33484556?tool=bestpractice.com [54]Kanayama G, Brower KJ, Wood RI, et al. Treatment of anabolic-androgenic steroid dependence: emerging evidence and its implications. Drug Alcohol Depend. 2010 Jun 1;109(1-3):6-13. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875348 http://www.ncbi.nlm.nih.gov/pubmed/20188494?tool=bestpractice.com Strongly encourage cessation; no tapering is required.[38]Brooks JH, Ahmad I, Easton G. Anabolic steroid use. BMJ. 2016 Oct 13;355:i5023. http://www.ncbi.nlm.nih.gov/pubmed/27737851?tool=bestpractice.com If complications such as suicidality or depression occur, antidepressant medications or admission to the hospital may be indicated.[33]National Institute on Drug Abuse. Anabolic steroids and other appearance and performance enhancing drugs (APEDs). May 2023 [internet publication]. https://nida.nih.gov/research-topics/anabolic-steroids [54]Kanayama G, Brower KJ, Wood RI, et al. Treatment of anabolic-androgenic steroid dependence: emerging evidence and its implications. Drug Alcohol Depend. 2010 Jun 1;109(1-3):6-13. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875348 http://www.ncbi.nlm.nih.gov/pubmed/20188494?tool=bestpractice.com Routine medical monitoring is not recommended (in the absence of medical problems); concerns exist that health checks that indicate no serious harm may precipitate continued AAS use.[11]de Ronde W, Smit DL. Anabolic androgenic steroid abuse in young males. Endocr Connect. 2020 Apr;9(4):R102-R111. https://www.doi.org/10.1530/EC-19-0557 http://www.ncbi.nlm.nih.gov/pubmed/32229704?tool=bestpractice.com [19]Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021 Jul 16;42(4):457-501. https://www.doi.org/10.1210/endrev/bnab001 http://www.ncbi.nlm.nih.gov/pubmed/33484556?tool=bestpractice.com
Collaboration with a psychiatrist for issues such as body-image disorders, major mood disorders, and substance use disorders is advised.[53]Pope HG Jr, Kanayama G. Body image disorders and anabolic steroid withdrawal hypogonadism in men. Endocrinol Metab Clin North Am. 2022 Mar;51(1):205-16. http://www.ncbi.nlm.nih.gov/pubmed/35216717?tool=bestpractice.com Counseling or psychotherapy may help to give people a more objective body image, to help them weigh risks and benefits of cessation, and to deal with the dysphoria that can accompany withdrawal from AASs.[54]Kanayama G, Brower KJ, Wood RI, et al. Treatment of anabolic-androgenic steroid dependence: emerging evidence and its implications. Drug Alcohol Depend. 2010 Jun 1;109(1-3):6-13. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875348 http://www.ncbi.nlm.nih.gov/pubmed/20188494?tool=bestpractice.com
It is important to focus on alternatives to AAS for improving or maintaining muscle mass and performance. Alternatives include well-balanced nutrition and an appropriate training program.[56]Thomas DT, Erdman KA, Burke LM. American College of Sports Medicine joint position statement. nutrition and athletic performance. Med Sci Sports Exerc. 2016 Mar;48(3):543-68. https://www.doi.org/10.1249/MSS.0000000000000852 http://www.ncbi.nlm.nih.gov/pubmed/26891166?tool=bestpractice.com [57]Burke LM, Castell LM, Casa DJ, et al. International Association of Athletics Federations consensus statement 2019: nutrition for athletics. Int J Sport Nutr Exerc Metab. 2019 Mar 1;29(2):73-84. https://www.doi.org/10.1123/ijsnem.2019-0065 http://www.ncbi.nlm.nih.gov/pubmed/30952204?tool=bestpractice.com [58]Jäger R, Kerksick CM, Campbell BI, et al. International Society of Sports Nutrition position stand: protein and exercise. J Int Soc Sports Nutr. 2017 Jun 20;14:20. https://www.doi.org/10.1186/s12970-017-0177-8 http://www.ncbi.nlm.nih.gov/pubmed/28642676?tool=bestpractice.com Referrals to a sports dietitian and physical trainer are necessary for optimal alternative results. Use of some supplements may be beneficial, but others risk harm to the user’s health or performance. Use of supplements requires the input of a well-informed sports nutrition professional.[59]Aragon AA, Schoenfeld BJ, Wildman R, et al. International Society of Sports Nutrition position stand: diets and body composition. J Int Soc Sports Nutr. 2017 Jun 14;14:16. https://www.doi.org/10.1186/s12970-017-0174-y http://www.ncbi.nlm.nih.gov/pubmed/28630601?tool=bestpractice.com
In cases of refusal to stop AAS use, the clinician should inform the patients about the known adverse effects with a focus on the cardiovascular system. The clinician should continue to encourage cessation of AAS use while monitoring for the development of complications. Addressing body dysmorphic disorder may improve the patient’s readiness to stop AAS use.
In some countries, an option to switch to prescription testosterone is considered to be a safer alternative to continued nonprescription AAS abuse, and facilitates tapering of testosterone over several months.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500. https://www.doi.org/10.1210/jc.2018-01882 http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com This approach may help to build a positive clinician-patient relationship, avoid AAS withdrawal symptoms, and prevent patients from using unregulated products bought online.[6]Thirumalai A, Anawalt BD. Androgenic steroids use and abuse: past, present, and future. Urol Clin North Am. 2022 Nov;49(4):645-63. http://www.ncbi.nlm.nih.gov/pubmed/36309421?tool=bestpractice.com Note that prescribing testosterone or other androgens for people with AAS use disorder may be illegal or considered professional misconduct in some regions; check local guidance.[19]Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021 Jul 16;42(4):457-501. https://www.doi.org/10.1210/endrev/bnab001 http://www.ncbi.nlm.nih.gov/pubmed/33484556?tool=bestpractice.com
For those patients who refuse to stop, harm reduction measures may still have benefits. The UK’s National Institute for Health and Care Excellence (NICE) recommends providing clean needles, syringes, and related equipment to adults who inject nonprescribed AASs.[60]National Institute for Health and Care Excellence. Needle and syringe programmes. March 2014 [internet publication]. https://www.nice.org.uk/guidance/ph52
management of harms associated with chronic use
Treatment recommended for SOME patients in selected patient group
Warrants an interdisciplinary approach as chronic effects of AAS use, or discontinuation, may require review by a cardiologist (atherosclerosis, cardiomyopathy), endocrinologist (sexual dysfunction, infertility, other effects of hypogonadism), psychiatrist (mood disorders, body dysmorphia, depression), or addiction specialist (substance abuse).
After stopping use of AAS, changes in hormones, lipid and cholesterol metabolism, and salt and water balance typically resolve within weeks to months. Muscle tone will start to decrease even with continued bodybuilding exercise. Patients may also notice decreased stamina and decreased exercise tolerance.[61]Sharma A, Grant B, Islam H, et al. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men. Best Pract Res Clin Endocrinol Metab. 2022 Sep;36(5):101691. https://www.doi.org/10.1016/j.beem.2022.101691 http://www.ncbi.nlm.nih.gov/pubmed/35999138?tool=bestpractice.com Patients may have withdrawal-associated dysphoria, which could prompt a relapse.[19]Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021 Jul 16;42(4):457-501. https://www.doi.org/10.1210/endrev/bnab001 http://www.ncbi.nlm.nih.gov/pubmed/33484556?tool=bestpractice.com
Patients should be reassured that many of the adverse effects associated with AAS use are reversible (e.g., acne, menstrual irregularities, dyslipidemia, elevated blood pressure, electrolyte abnormalities, needle marks) and will resolve within weeks to months of discontinuing the AAS.[38]Brooks JH, Ahmad I, Easton G. Anabolic steroid use. BMJ. 2016 Oct 13;355:i5023. http://www.ncbi.nlm.nih.gov/pubmed/27737851?tool=bestpractice.com Topical treatments may be used for acne.
Some hormone-induced changes (including hair distribution/baldness, voice depth, hirsutism, gynecomastia, clitoral hypertrophy, infertility, testicular atrophy, short stature in adolescents) may be permanent.[19]Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021 Jul 16;42(4):457-501. https://www.doi.org/10.1210/endrev/bnab001 http://www.ncbi.nlm.nih.gov/pubmed/33484556?tool=bestpractice.com [20]American College of Obstetricians and Gynecologists. ACOG committee opinion no. 484 (reaffirmed 2021): performance enhancing anabolic steroid abuse in women. Obstet Gynecol. 2011 Apr;117(4):1016-8. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2011/04/performance-enhancing-anabolic-steroid-abuse-in-women http://www.ncbi.nlm.nih.gov/pubmed/21422881?tool=bestpractice.com
Secondary hypogonadism can be confirmed with an early morning serum testosterone and gonadotropin levels. All other causes of secondary hypogonadism should be excluded. In men who have been on AAS for under a year, cessation of AAS use is likely to be sufficient to restore fertility. However, in men who have been on AAS for over a year and are infertile, recovery of the hypothalamic-pituitary-gonadal axis may take a long time.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500. https://www.doi.org/10.1210/jc.2018-01882 http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
Surgical options may be considered for keloids and for irreversible gynecomastia. Cosmetic options (e.g., laser treatment) may be considered for hirsutism.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer